Aarti Pharmalabs Limited (NSE:AARTIPHARM)

Market Cap	64.32B -15.8%
Revenue (ttm)	18.19B -14.0%
Net Income	1.75B -35.9%
EPS	19.25 -35.9%
Shares Out	90.66M
PE Ratio	36.85
Forward PE	39.86
Dividend	3.50 (0.49%)
Ex-Dividend Date	Feb 16, 2026

Volume	138,493
Open	706.45
Previous Close	702.95
Day's Range	703.00 - 713.45
52-Week Range	585.00 - 971.00
Beta	0.22
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 7, 2026

About Aarti Pharmalabs

Aarti Pharmalabs Limited, together with its subsidiaries, manufactures and sells active pharmaceutical ingredients, pharmaceutical intermediates, and xanthine derivatives in India and internationally. The company offers active pharmaceutical ingredients for various therapeutic areas, such as cardiovascular, anti-asthmatic, anti-cancer, anti-coagulant, anti-diabetic, arthritis, central nervous system agent, skincare, overactive bladder, calcimimetic, decongestant, anti-thalassaemic, analgesic, and ophthalmologic medications. It also provides con...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2019
• Employees: 2,162
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: AARTIPHARM

Financial Performance

In fiscal year 2026, Aarti Pharmalabs's revenue was 18.19 billion, a decrease of -13.98% compared to the previous year's 21.15 billion. Earnings were 1.75 billion, a decrease of -35.86%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jul 10, 2026

Data Sources Report a data error